Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

被引:3950
|
作者
Whiteford, Harvey A. [1 ,3 ]
Degenhardt, Louisa [4 ,5 ]
Rehm, Juergen [6 ,7 ]
Baxter, Amanda J. [1 ,3 ]
Ferrari, Alize J. [1 ,3 ]
Erskine, Holly E. [1 ,3 ]
Charlson, Fiona J. [1 ,3 ]
Norman, Rosana E. [1 ,2 ]
Flaxman, Abraham D. [8 ]
Johns, Nicole [8 ]
Burstein, Roy [8 ]
Murray, Christopher J. L. [8 ]
Vos, Theo [8 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia
[2] Univ Queensland, Queensland Childrens Med Res Inst, Herston, Qld, Australia
[3] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia
[4] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[5] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia
[6] Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada
[7] Tech Univ Dresden, Epidemiol Res Unit, D-01062 Dresden, Germany
[8] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA
来源
LANCET | 2013年 / 382卷 / 9904期
基金
比尔及梅琳达.盖茨基金会; 英国医学研究理事会;
关键词
ILLICIT DRUG-USE; SYSTEMATIC ANALYSIS; COST-EFFECTIVENESS; LOW-INCOME; 187; COUNTRIES; RISK-FACTORS; 21; REGIONS; HEALTH; PREVALENCE; DISABILITY;
D O I
10.1016/S0140-6736(13)61611-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the burden of disease attributable to mental and substance use disorders in terms of disability-adjusted life years (DALYs), years of life lost to premature mortality (YLLs), and years lived with disability (YLDs). Methods For each of the 20 mental and substance use disorders included in GBD 2010, we systematically reviewed epidemiological data and used a Bayesian meta-regression tool, DisMod-MR, to model prevalence by age, sex, country, region, and year. We obtained disability weights from representative community surveys and an internet-based survey to calculate YLDs. We calculated premature mortality as YLLs from cause of death estimates for 1980-2010 for 20 age groups, both sexes, and 187 countries. We derived DALYs from the sum of YLDs and YLLs. We adjusted burden estimates for comorbidity and present them with 95% uncertainty intervals. Findings In 2010, mental and substance use disorders accounted for 183.9 million DALYs (95% UI 153.5 million216 .7 million), or 7.4% (6.2-8.6) of all DALYs worldwide. Such disorders accounted for 8.6 million YLLs (6.5 million-12.1 million; 0.5% [0.4-0.7] of all YLLs) and 175.3 million YLDs (144.5 million-207.8 million; 22.9% [18.6-27.2] of all YLDs). Mental and substance use disorders were the leading cause of YLDs worldwide. Depressive disorders accounted for 40.5% (31.7-49.2) of DALYs caused by mental and substance use disorders, with anxiety disorders accounting for 14.6% (11.2-18.4), illicit drug use disorders for 10.9% (8.9-13.2), alcohol use disorders for 9.6% (7.7-11.8), schizophrenia for 7.4% (5.0-9.8), bipolar disorder for 7.0% (4.4-10.3), pervasive developmental disorders for 4.2% (3.2-5.3), childhood behavioural disorders for 3.4% (2.2-4.7), and eating disorders for 1.2% (0.9-1.5). DALYs varied by age and sex, with the highest proportion of total DALYs occurring in people aged 10-29 years. The burden of mental and substance use disorders increased by 37.6% between 1990 and 2010, which for most disorders was driven by population growth and ageing. Interpretation Despite the apparently small contribution of YLLs-with deaths in people with mental disorders coded to the physical cause of death and suicide coded to the category of injuries under self-harm-our fi ndings show the striking and growing challenge that these disorders pose for health systems in developed and developing regions. In view of the magnitude of their contribution, improvement in population health is only possible if countries make the prevention and treatment of mental and substance use disorders a public health priority.
引用
收藏
页码:1575 / 1586
页数:12
相关论文
共 50 条
  • [21] Neurological disorders in the Global Burden of Disease 2010 study
    Stovner, L. J.
    Hoff, J. M.
    Svalheim, S.
    Gilhus, N. E.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 : 1 - 6
  • [22] Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010
    Feigin, Valery L.
    Forouzanfar, Mohammad H.
    Krishnamurthi, Rita
    Mensah, George A.
    Connor, Myles
    Bennett, Derrick A.
    Moran, Andrew E.
    Sacco, Ralph L.
    Anderson, Laurie
    Truelsen, Thomas
    O'Donnell, Martin
    Venketasubramanian, Narayanaswamy
    Barker-Collo, Suzanne
    Lawes, Carlene M. M.
    Wang, Wenzhi
    Shinohara, Yukito
    Witt, Emma
    Ezzati, Majid
    Naghavi, Mohsen
    Murray, Christopher
    LANCET, 2014, 383 (9913): : 245 - 255
  • [23] The global burden of gout: estimates from the Global Burden of Disease 2010 study
    Smith, Emma
    Hoy, Damian
    Cross, Marita
    Merriman, Tony R.
    Vos, Theo
    Buchbinder, Rachelle
    Woolf, Anthony
    March, Lyn
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (08) : 1470 - 1476
  • [24] The burden of mental disorders in Nepal between 1990 and 2019: Findings from the Global Burden of Disease Study 2019
    Dhungana, Raja Ram
    Pandey, Achyut Raj
    Joshi, Suira
    Luitel, Nagendra P.
    Marahatta, Kedar
    Aryal, Krishna Kumar
    Dhimal, Meghnath
    CAMBRIDGE PRISMS-GLOBAL MENTAL HEALTH, 2023, 10
  • [25] How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?
    Whiteford, Harvey A.
    Ferrari, Alize J.
    Baxter, Amanda J.
    Charlson, Fiona J.
    Degenhardt, Louisa
    CURRENT OPINION IN PSYCHIATRY, 2013, 26 (04) : 376 - 383
  • [26] Burden and trends of mental disorders in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019
    Deng, Yang
    Sun, Siwei
    Wu, Shixing
    Chen, Kun
    Liu, Yan
    Wei, Wannian
    Bei, Ning
    Qiu, Chengjun
    Li, Xiaomei
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2024, 59 (09) : 1563 - 1576
  • [27] The burden of cardiovascular disease attributable to high fasting plasma glucose:Findings from the global burden of disease study 2019
    Dong, Xin-Jiang
    Zhang, Xiao-Qi
    Wang, Bei-Bei
    Hou, Fei-Fei
    Jiao, Yang
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (05)
  • [28] Estimating the burden of disease attributable to illicit drug use and mental disorders: what is 'Global Burden of Disease 2005' and why does it matter?
    Degenhardt, Louisa
    Whiteford, Harvey
    Hall, Wayne
    Vos, Theo
    ADDICTION, 2009, 104 (09) : 1466 - 1471
  • [29] The burden of disease in Spain: results from the global burden of disease study 2010
    Maria Haro, Josep
    Tyrovolas, Stefanos
    Garin, Noe
    Diaz-Torne, Cesar
    Carmona, Loreto
    Sanchez-Riera, Lidia
    Perez-Ruiz, Fernando
    Murray, Christopher J. L.
    BMC MEDICINE, 2014, 12
  • [30] Burden of Malaria in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010
    Badirzadeh, Alireza
    Naderimagham, Shohreh
    Asadgol, Zahra
    Mokhayeri, Yaser
    Khosravi, Azin
    Tohidnejad, Elham
    Vosoogh-Moghaddam, Abbas
    Khoshdel, Ali
    Rezaei, Nazila
    Kompani, Farzad
    ARCHIVES OF IRANIAN MEDICINE, 2016, 19 (04) : 241 - 247